Biotech major Biocon on Wednesday reported a Rs 92 crore consolidated net profit for the third quarter of 2017-18, registering 46 per cent decline annually from Rs 171 crore in the same period year ago.
Sequentially, net profit, however, increased 33 per cent from Rs 69 crore last quarter.
In a regulatory filing on the BSE, the city-based pharma firm said consolidated revenue remained flat annually at Rs 1,092 crore from the same period year ago, but 7 per cent up sequentially from Rs 1,019 crore quarter ago.
Earnings before income, depreciation and ammortisation (Ebitda) also declined 21 per cent annually to Rs 256 crore from Rs 324 crore in the same period year ago but 10 per cent up sequentially from Rs 233 crore last quarter.
Ebitda margin for the quarter was 23 per cent.
--IANS
fb/vd